Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: dyspnea on exertion major surgical or invasive procedure: coronary artery bypass graft x 2 (lima to lad, svg to om)/ mitral valve replacement (29mm ce tissue valve) history of present illness: 77 y/o male with known cad and multiple cardiac risk factors who had cardiac cath in which revealed two vessel disease and mitral regurgitation. referred for surgical intervention. past medical history: coronary artery disease, hypertension, hypercholesterolemia, cataracts s/p surgery, s/p varicose veins stripping right leg, s/p multiple hernia repairs, s/p decortication of empyema social history: semi-retired painter. lives with wife. quit smoking in . drinks alcoholic beverages/day. family history: non-contributory physical exam: general: wd/wn male in nad skin: unremarkable heent: eomi, heent, ncat, op benign neck: supple, from, -jvd chest: ctab -w/r/r, healed incision heart: rrr, -c/r/m/g abd: soft, nt/nd +bs ext: warm, well-perfused, -edema, bilateral varicosities r>l neuro: a&o x 3, mae, non-focal pertinent results: echo : pre-cpb: left ventricular wall thicknesses are normal. the left ventricular cavity size is normal. regional left ventricular wall motion is normal. overall left ventricular systolic function is low normal (lvef 50-55%). there are simple atheroma in the aortic root, ascending aorta, aortic arch, descending thoracic aorta. the aortic valve leaflets are mildly thickened. no masses or vegetations are seen on the aortic valve. there is no aortic valve stenosis. trace aortic regurgitation is seen. the mitral valve leaflets are mildly thickened. no mass or vegetation is seen on the mitral valve. mild to moderate (+) mitral regurgitation is seen. there is a central jet. there is a normal width of the annulus of 3.0 cm. lupv shows no flow reversal. post-cpb: well-seated bioprosthetic valve in the mitral position with trivial mr. normal lv systolic function on phenylephrine, av pacing. normal aortic contours. cxr : there is stable postoperative widening of the cardiomediastinal silhouette. in addition, the upper mediastinal widening and slight tracheal narrowing demonstrated on preop chest radiograph, appears unchanged. there has been interval removal of the endotracheal tube, nasogastric tube, right internal jugular venous access sheath and pulmonary artery catheter, mediastinal drains and left-sided chest tube. there is no definite pneumothorax. left lower lobe atelectasis is improved. there is mild increase in right basilar atelectasis. mitral valve prosthesis in place. echo : 1. the left atrium is mildly dilated. 2. left ventricular wall thickness, cavity size, and systolic function are normal (lvef>55%). regional left ventricular wall motion is normal. 3. the right ventricular cavity is dilated. right ventricular systolic function appears depressed. 4. the ascending aorta is mildly dilated. 5. the aortic valve leaflets (3) are mildly thickened. trace aortic regurgitation is seen. 6. a bioprosthetic mitral valve prosthesis is present. the mitral prosthesis appears well seated, with normal leaflet motion and transvalvular gradients. trivial mitral regurgitation is seen. 03:26pm blood wbc-9.0 rbc-2.85*# hgb-9.0*# hct-25.9*# mcv-91 mch-31.6 mchc-34.8 rdw-13.4 plt ct-85* 07:20am blood wbc-12.3* rbc-3.83* hgb-12.1* hct-33.1* mcv-86 mch-31.5 mchc-36.5* rdw-14.7 plt ct-132* 04:54pm blood pt-15.1* ptt-48.4* inr(pt)-1.4* 03:37am blood pt-13.6* ptt-26.8 inr(pt)-1.2* 04:54pm blood urean-18 creat-0.7 cl-113* hco3-24 07:20am blood glucose-125* urean-23* creat-1.0 na-136 k-4.2 cl-97 hco3-29 angap-14 brief hospital course: mr. was a same day admit and on was brought directly to the operating room where he underwent a coronary artery bypass graft x 2 and mitral valve replacement (tissue). please see operative report for surgical details. he was transferred to the csru for invasive monitoring in stable condition. he remained intubated until post-op day one when he was weaned from sedation, awoke neurologically intact and was extubated. post-operatively he required platelets, ffp, and rbc's secondary to bleeding. chest tubes were removed on post-op day two and he was then transferred to the step-down floor. on post-op day three his epicardial pacing wires were removed and an echo was preformed secondary to st elevation. there appeared to be no wall motion abnormalities. physical therapy followed patient throughout hospital course for strength and mobility. on post-op day four he appeared to be doing well and was discharged home with vna services and the appropriated follow-up appointments. medications on admission: zocor 20mg qd, lisinopril 20mg qd, atenolol 25mg qd, aspirin 81mg qd, voltaren gtts od qid discharge medications: 1. metoprolol tartrate 25 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*2* 2. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). disp:*60 capsule(s)* refills:*2* 3. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). disp:*30 tablet, delayed release (e.c.)(s)* refills:*2* 4. oxycodone-acetaminophen 5-325 mg tablet sig: 1-2 tablets po every 4-6 hours as needed for pain. disp:*50 tablet(s)* refills:*0* 5. simvastatin 10 mg tablet sig: two (2) tablet po daily (daily). disp:*60 tablet(s)* refills:*2* 6. lisinopril 10 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 7. lasix 20 mg tablet sig: one (1) tablet po twice a day for 7 days. disp:*14 tablet(s)* refills:*0* 8. potassium chloride 20 meq tab sust.rel. particle/crystal sig: one (1) tab sust.rel. particle/crystal po twice a day for 7 days. disp:*14 tab sust.rel. particle/crystal(s)* refills:*0* 9. ranitidine hcl 150 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*2* discharge disposition: home with service facility: vna discharge diagnosis: coronary artery disease s/p coronary artery bypass graft x 2 mitral regurgitation s/p mitral valve replacement pmh: hypertension, hypercholesterolemia, cataracts s/p surgery, s/p varicose veins stripping right leg, s/p multiple hernia repairs, s/p decortication of empyema discharge condition: good discharge instructions: follow medications on discharge instructions. do not drive for 4 weeks. do not lift more than 10 lbs for 2 months. shower daily, let water flow over wounds, pat dry with a towel. do not use lotions, creams, or powders on wounds. call our office for sternal drainage, temp >101.5 followup instructions: make an appointment with dr. for 1-2 weeks. make an appointment with dr. for 2-3 weeks. make an appointment with dr. for 4 weeks. procedure: single internal mammary-coronary artery bypass extracorporeal circulation auxiliary to open heart surgery (aorto)coronary bypass of one coronary artery open and other replacement of mitral valve with tissue graft transfusion of packed cells transfusion of platelets diagnoses: coronary atherosclerosis of native coronary artery mitral valve disorders unspecified essential hypertension other and unspecified hyperlipidemia other and unspecified angina pectoris 

Answer: The patient is high likely exposed to